Complete Filing Data
ALX ONCOLOGY HOLDINGS INC reported Stockholders Equity of $25.98 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ALX ONCOLOGY HOLDINGS INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$101.7M | -$134.9M | -$160.8M | -$123.5M | -$83.5M | -$45.7M | -$19.2M | -$13.7M |
| Operating Expenses | $104.0M | $142.5M | $170.3M | $127.4M | $83.6M | $44.8M | $24.0M | $15.8M |
| Research And Development Expense | $77.0M | $116.4M | $141.8M | $98.4M | $60.2M | $29.0M | $16.3M | $11.3M |
| Operating Income Loss | -$104.0M | -$142.5M | -$170.3M | -$127.4M | -$83.6M | -$43.7M | -$19.2M | -$13.7M |
| General And Administrative Expense | $23.9M | $26.1M | $28.5M | $29.0M | $23.4M | $14.8M | $3.3M | $2.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$247.0K | $19.0K | $1.1M | -$845.0K | ||||
| Other Nonoperating Income Expense | -$36.0K | -$20.0K | $389.0K | -$22.0K | -$7.0K | -$1.3M | -$5.0K | |
| Comprehensive Income Net Of Tax | -$101.9M | -$134.8M | -$159.7M | -$124.3M | -$83.5M | -$50.9M | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$101.7M | -$134.9M | -$160.8M | -$123.4M | -$83.5M | -$45.5M | -$19.2M | -$13.7M |
| Net Income Loss Available To Common Stockholders Basic | -$123.5M | -$83.5M | -$50.9M | -$23.3M | -$17.4M | |||
| Interest Expense | $1.6M | $1.7M | $1.6M | $238.0K | $13.0K | |||
| Income Loss From Continuing Operations Per Basic And Diluted Share | -$2.07 | -$2.76 | -$7.56 | -$6.33 | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $64.0K | -$21.0K | $241.0K | $34.0K | $45.0K |
| Interest Income Expense Nonoperating Net | $4.3M | $91.0K | $124.0K | -$21.0K | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $1.2M | $4.8M | $2.1M | |||
| Income Loss From Continuing Operations Per Diluted Share | -$3.03 | -$2.07 | -$2.76 | |||||
| Income Loss From Continuing Operations Per Basic Share | -$3.03 | -$2.07 | -$2.76 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$22.1M | -$25.9M | -$30.8M | -$30.7M | -$39.4M | -$35.6M | -$51.0M | -$34.2M | -$30.2M | -$35.3M | -$32.9M | -$24.5M | -$24.6M | -$16.3M | -$14.2M | -$10.2M | -$11.3M | -$5.5M | -$3.0M | -$4.2M | -$4.2M | ||
| Operating Expenses | $22.5M | $26.6M | $31.8M | $32.6M | $41.5M | $37.8M | $53.3M | $36.8M | $32.2M | $36.7M | $33.8M | $24.7M | $24.6M | $16.3M | $14.2M | $17.8M | $9.8M | $11.3M | $5.9M | $8.9M | $4.3M | $5.5M | $5.3M |
| Research And Development Expense | $17.4M | $18.0M | $23.9M | $26.5M | $34.7M | $31.7M | $45.8M | $29.5M | $24.8M | $29.4M | $26.7M | $17.1M | $18.2M | $11.2M | $9.8M | $5.3M | $7.7M | $3.8M | $2.2M | $3.6M | |||
| Operating Income Loss | -$22.5M | -$26.6M | -$31.8M | -$32.6M | -$41.5M | -$37.8M | -$53.3M | -$36.8M | -$32.2M | -$36.7M | -$33.8M | -$24.7M | -$24.6M | -$16.3M | -$14.2M | -$9.8M | -$10.8M | -$5.2M | -$3.0M | -$4.2M | |||
| General And Administrative Expense | $5.1M | $5.5M | $7.9M | $6.1M | $6.9M | $6.0M | $7.5M | $7.3M | $7.4M | $7.3M | $7.0M | $7.7M | $6.4M | $5.1M | $4.4M | $4.5M | $3.2M | $1.5M | $938.0K | $679.0K | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $7.0K | -$82.0K | -$157.0K | $636.0K | -$101.0K | -$228.0K | $86.0K | -$224.0K | $757.0K | -$248.0K | -$650.0K | -$606.0K | |||||||||||
| Other Nonoperating Income Expense | -$6.0K | -$2.0K | -$11.0K | $3.0K | -$8.0K | -$14.0K | -$1.0K | $324.0K | $95.0K | -$7.0K | -$5.0K | -$8.0K | $14.0K | $2.0K | -$2.0K | -$111.0K | -$305.0K | $7.0K | |||||
| Comprehensive Income Net Of Tax | -$22.1M | -$26.0M | -$30.9M | -$30.1M | -$39.5M | -$35.8M | -$50.9M | -$34.4M | -$29.4M | -$35.6M | -$33.6M | -$25.1M | -$16.3M | -$14.2M | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$24.6M | -$16.3M | -$14.2M | -$10.1M | -$11.3M | -$5.5M | -$3.0M | -$4.2M | |||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$24.6M | -$16.3M | -$14.2M | -$18.8M | -$10.8M | -$14.0M | -$7.4M | -$8.8M | -$4.1M | -$5.2M | -$5.1M | ||||||||||||
| Interest Expense | $408.0K | $405.0K | $406.0K | $446.0K | $429.0K | $427.0K | $391.0K | $372.0K | $387.0K | $2.0K | $2.0K | $3.0K | |||||||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | -$0.60 | -$0.61 | -$0.40 | -$0.35 | -$0.50 | -$0.36 | -$4.41 | -$2.37 | -$2.83 | -$1.33 | -$1.68 | -$1.71 | |||||||||||
| Income Tax Expense Benefit | $35.0K | $20.0K | $4.0K | $8.0K | $8.0K | ||||||||||||||||||
| Interest Income Expense Nonoperating Net | $876.0K | $225.0K | -$4.0K | $23.0K | $25.0K | -$226.0K | -$219.0K | -$215.0K | |||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $527.0K | $655.0K | $1.3M | $1.3M | |||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | |||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $26.0M | $113.6M | $189.7M | $263.5M | $363.0M | $429.8M | -$70.6M | -$51.8M | -$38.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.4M | $17.6M | $22.5M | $48.9M | $363.7M | $434.2M | $9.0M | $8.3M | $22.1M |
| Cash And Cash Equivalents At Carrying Value | $16.4M | $17.6M | $22.4M | $48.8M | $363.7M | $434.2M | $9.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.2M | -$4.8M | -$26.4M | -$314.8M | -$70.6M | $425.2M | $755.0K | -$13.8M | |
| Retained Earnings Accumulated Deficit | -$722.8M | -$621.1M | -$486.3M | -$325.5M | -$202.0M | -$118.5M | -$72.8M | ||
| Property Plant And Equipment Net | $1.2M | $2.9M | $3.6M | $3.9M | $897.0K | $52.0K | $860.0K | ||
| Prepaid Expense And Other Assets Current | $5.9M | $6.6M | $5.9M | $4.8M | $3.4M | $1.8M | $256.0K | ||
| Other Liabilities Noncurrent | $4.0M | $6.2M | $7.2M | $5.3M | $1.8M | $5.0K | $547.0K | ||
| Liabilities Current | $24.6M | $18.5M | $36.0M | $28.3M | $15.3M | $6.2M | $5.0M | ||
| Liabilities And Stockholders Equity | $59.0M | $147.8M | $242.6M | $306.5M | $380.2M | $436.1M | $10.7M | ||
| Liabilities | $33.1M | $34.2M | $52.8M | $43.0M | $17.1M | $6.2M | $11.0M | ||
| Common Stock Value | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | ||
| Assets Current | $50.7M | $134.4M | $188.7M | $271.0M | $367.0M | $436.0M | $9.8M | ||
| Assets | $59.0M | $147.8M | $242.6M | $306.5M | $380.2M | $436.1M | $10.7M | ||
| Additional Paid In Capital Common Stock | $748.7M | $734.4M | $675.7M | $589.7M | $565.0M | $548.3M | $2.1M | ||
| Accrued Liabilities And Other Liabilities | $14.4M | $13.4M | $26.9M | $18.6M | $9.9M | $6.1M | $1.2M | ||
| Accounts Payable Current | $4.9M | $4.5M | $8.6M | $8.1M | $3.8M | $4.0K | $3.7M | ||
| Other Assets Noncurrent | $3.6M | $7.0M | $14.9M | $14.9M | $12.3M | $10.0K | $7.0K | ||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $962.0K | $1.2M | $1.4M | $2.1M | $237.0K | $7.0K | $20.0K | ||
| Finance Lease Principal Payments | $929.0K | $827.0K | $388.0K | $388.0K | $281.0K | ||||
| Operating Finance Lease Right Of Use Asset Amortization Expense | $1.7M | $1.8M | $1.3M | $1.1M | $685.0K | ||||
| Long Term Debt Noncurrent | $4.5M | $9.5M | $9.6M | $9.4M | $5.4M | ||||
| Restricted Cash And Cash Equivalents At Carrying Value | $66.0K | $66.0K | $66.0K | $66.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.2M | $4.7M | $6.5M | $940.0K | |||||
| Short Term Investments | $28.4M | $110.2M | $160.3M | $217.4M | |||||
| Long Term Investments | $3.5M | $3.5M | $35.4M | $16.7M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $28.0K | $275.0K | $256.0K | -$845.0K | |||||
| Preferred Stock Dividends Income Statement Impact | $5.2M | $4.0M | $3.7M | ||||||
| Other Liabilities Current | $0.00 | $149.0K | $543.0K | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $44.8M | $64.4M | $88.3M | $136.8M | $159.3M | $164.2M | $168.8M | $212.7M | $240.4M | $287.0M | $316.3M | $343.6M | $385.2M | $405.0M | $418.5M | $252.0M | -$84.4M | -$75.9M | -$63.0M | -$60.0M | -$55.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $23.5M | $19.4M | $20.7M | $16.2M | $15.6M | $14.1M | $19.7M | $38.1M | $63.3M | $49.1M | $66.4M | $159.2M | $385.1M | $410.0M | $429.9M | $259.5M | $98.1M | $105.0M | $5.9M | $9.1M | |
| Cash And Cash Equivalents At Carrying Value | $23.4M | $19.3M | $20.6M | $16.1M | $15.5M | $14.0M | $19.6M | $38.0M | $63.2M | $49.1M | $66.4M | $159.1M | $385.1M | $410.0M | $429.9M | $259.5M | $98.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.0M | -$8.4M | $14.4M | -$204.5M | -$4.4M | $96.0M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$700.0M | -$677.8M | -$651.9M | -$592.0M | -$561.3M | -$521.9M | -$440.8M | -$389.8M | -$355.7M | -$294.8M | -$259.4M | -$226.5M | -$173.5M | -$149.0M | -$132.7M | -$99.7M | -$89.6M | ||||
| Property Plant And Equipment Net | $1.4M | $1.5M | $2.7M | $3.1M | $3.3M | $3.4M | $3.6M | $3.8M | $3.9M | $2.3M | $1.6M | $1.3M | $562.0K | $167.0K | $47.0K | $45.0K | $37.0K | ||||
| Prepaid Expense And Other Assets Current | $5.9M | $5.9M | $4.7M | $7.3M | $12.0M | $10.4M | $9.1M | $6.7M | $4.6M | $5.9M | $3.5M | $4.9M | $3.8M | $2.3M | $2.5M | $2.4M | $1.4M | ||||
| Other Liabilities Noncurrent | $4.4M | $5.1M | $5.6M | $6.7M | $7.1M | $6.5M | $6.6M | $6.2M | $6.4M | $5.5M | $5.7M | $4.8M | $2.1M | $2.3M | $297.0K | $47.0K | $820.0K | ||||
| Liabilities Current | $27.7M | $18.8M | $18.7M | $32.3M | $38.4M | $32.2M | $35.1M | $17.6M | $21.9M | $25.2M | $24.0M | $15.3M | $12.5M | $14.0M | $14.1M | $7.2M | $7.7M | ||||
| Liabilities And Stockholders Equity | $82.7M | $95.3M | $120.9M | $185.7M | $214.6M | $212.7M | $220.1M | $245.9M | $278.1M | $317.7M | $346.0M | $363.7M | $399.7M | $421.3M | $432.9M | $262.4M | $103.1M | ||||
| Liabilities | $37.9M | $30.9M | $32.6M | $48.9M | $55.3M | $48.5M | $51.4M | $33.2M | $37.8M | $30.7M | $29.7M | $20.1M | $14.6M | $16.3M | $14.4M | $10.4M | $12.5M | ||||
| Common Stock Value | $54.0K | $54.0K | $53.0K | $53.0K | $52.0K | $50.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $40.0K | $40.0K | $40.0K | $37.0K | $3.0K | ||||
| Assets Current | $66.5M | $85.3M | $102.5M | $155.9M | $168.7M | $167.9M | $199.1M | $219.6M | $232.5M | $290.8M | $316.8M | $321.5M | $389.0M | $412.3M | $432.3M | $262.4M | $100.7M | ||||
| Assets | $82.7M | $95.3M | $120.9M | $185.7M | $214.6M | $212.7M | $220.1M | $245.9M | $278.1M | $317.7M | $346.0M | $363.7M | $399.7M | $421.3M | $432.9M | $262.4M | $103.1M | ||||
| Additional Paid In Capital Common Stock | $744.7M | $742.2M | $740.0M | $728.2M | $720.6M | $686.0M | $609.7M | $602.8M | $596.1M | $583.2M | $577.0M | $570.7M | $558.7M | $554.0M | $551.2M | $351.7M | $5.2M | ||||
| Accrued Liabilities And Other Liabilities | $16.8M | $10.9M | $13.0M | $24.4M | $30.1M | $25.6M | $21.9M | $13.2M | $11.2M | $16.6M | $12.7M | $8.7M | $7.2M | $7.4M | $6.8M | $3.2M | $4.1M | ||||
| Accounts Payable Current | $6.6M | $4.9M | $3.9M | $7.9M | $8.1M | $6.2M | $13.0M | $4.1M | $9.8M | $5.9M | $8.7M | $5.1M | $3.7M | $5.8M | $7.4M | $1.4M | $1.9M | ||||
| Other Assets Noncurrent | $9.0M | $4.3M | $6.5M | $12.7M | $13.1M | $14.3M | $11.0M | $10.9M | $13.5M | $16.3M | $16.7M | $15.7M | $10.2M | $8.8M | $536.0K | $2.4M | |||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $1.1M | $1.3M | $1.7M | $147.0K | |||||||||||||||||
| Finance Lease Principal Payments | $307.0K | $175.0K | $107.0K | $105.0K | |||||||||||||||||
| Operating Finance Lease Right Of Use Asset Amortization Expense | $478.0K | $449.0K | $305.0K | $318.0K | $58.0K | ||||||||||||||||
| Long Term Debt Noncurrent | $5.8M | $7.0M | $8.2M | $9.8M | $9.8M | $9.7M | $9.6M | $9.5M | $9.5M | $3.2M | $3.9M | ||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $526.0K | $1.6M | $1.1M | -$107.0K | |||||||||||||||||
| Short Term Investments | $37.2M | $60.0M | $77.2M | $132.5M | $141.2M | $143.4M | $170.4M | $174.8M | $164.8M | $235.9M | $247.0M | $157.5M | |||||||||
| Long Term Investments | $5.8M | $4.2M | $9.2M | $14.0M | $29.5M | $27.0M | $6.4M | $11.6M | $28.2M | $8.2M | $10.9M | $25.1M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $43.0K | $36.0K | $118.0K | $563.0K | -$73.0K | $28.0K | -$226.0K | -$312.0K | -$88.0K | -$1.5M | -$1.3M | -$606.0K | |||||||||
| Preferred Stock Dividends Income Statement Impact | $578.0K | $2.6M | $2.0M | $1.1M | $981.0K | ||||||||||||||||
| Other Liabilities Current | $0.00 | $40.0K | $48.0K | $63.0K | $226.0K | $375.0K | $265.0K | $260.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $14.0K | $1.6M | $269.0K | $567.0K | $2.6M | $299.0K | $10.0K | $7.0K |
| Share Based Compensation | $12.6M | $27.1M | $26.3M | $23.8M | $13.9M | $5.4M | $297.0K | $269.0K |
| Payments To Acquire Property Plant And Equipment | $212.0K | $447.0K | $1.3M | $1.4M | $666.0K | $31.0K | $353.0K | $653.0K |
| Net Cash Provided By Used In Operating Activities | -$84.1M | -$121.9M | -$130.4M | -$89.2M | -$68.1M | -$38.3M | -$14.2M | -$13.2M |
| Net Cash Provided By Used In Investing Activities | $82.6M | $86.3M | $44.7M | -$235.4M | -$4.9M | $610.0K | -$353.0K | -$653.0K |
| Net Cash Provided By Used In Financing Activities | $362.0K | $30.8M | $59.3M | $9.9M | $2.5M | $462.9M | $15.4M | $1.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$658.0K | $692.0K | $1.3M | $1.5M | $1.7M | $1.5M | -$744.0K | -$897.0K |
| Increase Decrease In Other Accrued Liabilities | $2.0M | -$12.6M | $11.2M | $7.0M | $3.3M | $5.0M | $134.0K | $9.0K |
| Increase Decrease In Accounts Payable | $421.0K | -$4.0M | $458.0K | $4.5M | $3.3M | -$3.7M | $3.0M | -$269.0K |
| Depreciation Depletion And Amortization | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | $431.0K |
| Increase Decrease In Other Noncurrent Liabilities | -$1.9M | -$2.1M | -$2.4M | -$977.0K | -$698.0K | -$4.0K | $136.0K | |
| Proceeds From Stock Options Exercised | $14.0K | $1.6M | $269.0K | $567.0K | $2.6M | $299.0K | $10.0K | $7.0K |
| Increase Decrease In Payable And Accrued Liabilities Due To Related Parties Current | -$149.0K | -$394.0K | -$1.1M | $20.0K | $1.4M | |||
| Increase Decrease In Other Operating Assets | $686.0K | -$7.4M | -$1.4M | -$750.0K | $9.7M | $10.0K | ||
| Payments To Acquire Investments | $51.6M | $107.4M | $246.6M | $376.8M | ||||
| Proceeds From Stock Plans | $24.0K | $351.0K | $523.0K | $336.0K | $202.0K | |||
| Proceeds From Sale Of Available For Sale Securities Debt | $134.4M | $194.1M | $292.6M | $142.8M | ||||
| Proceeds From Issuance Of Common Stock | $1.7M | $29.7M | $368.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $1.0K | $534.0K | $861.0K | $237.0K | $112.0K | $5.0K | $155.0K | $185.0K | $533.0K | $464.0K | $1.0M | $299.0K | |||
| Share Based Compensation | $5.2M | $7.0M | $6.4M | $5.5M | $1.8M | $151.0K | |||||||||
| Payments To Acquire Property Plant And Equipment | $60.0K | $148.0K | $690.0K | $589.0K | $7.0K | $10.0K | |||||||||
| Net Cash Provided By Used In Operating Activities | -$24.7M | -$37.9M | -$27.8M | -$20.7M | -$5.1M | -$9.0M | |||||||||
| Net Cash Provided By Used In Investing Activities | $27.6M | $26.5M | $42.3M | -$183.9M | -$7.0K | -$10.0K | |||||||||
| Net Cash Provided By Used In Financing Activities | $65.0K | $3.1M | -$107.0K | $80.0K | $778.0K | $105.0M | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.9M | $4.5M | -$170.0K | $1.6M | $453.0K | $931.0K | |||||||||
| Increase Decrease In Other Accrued Liabilities | -$97.0K | -$1.1M | -$5.6M | -$1.3M | $585.0K | -$614.0K | |||||||||
| Increase Decrease In Accounts Payable | -$556.0K | -$2.3M | $1.8M | $1.6M | $7.3M | -$1.8M | |||||||||
| Depreciation Depletion And Amortization | $211.0K | $214.0K | $213.0K | $58.0K | $5.0K | $113.0K | |||||||||
| Increase Decrease In Other Noncurrent Liabilities | -$507.0K | -$630.0K | -$191.0K | -$296.0K | $292.0K | -$27.0K | |||||||||
| Proceeds From Stock Options Exercised | $237.0K | $185.0K | $778.0K | ||||||||||||
| Increase Decrease In Payable And Accrued Liabilities Due To Related Parties Current | -$101.0K | -$168.0K | -$820.0K | -$184.0K | |||||||||||
| Increase Decrease In Other Operating Assets | -$12.0K | -$149.0K | -$1.2M | $317.0K | $583.0K | ||||||||||
| Payments To Acquire Investments | $15.8M | $31.3M | $72.2M | $183.3M | |||||||||||
| Proceeds From Stock Plans | |||||||||||||||
| Proceeds From Sale Of Available For Sale Securities Debt | $43.5M | $57.9M | $115.2M | ||||||||||||
| Proceeds From Issuance Of Common Stock | $372.0K | $3.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.52B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 54.4M | 53.1M | 50.0M | 40.9M | 40.6M | 39.8M | 3.2M | |
| Common Stock Shares Outstanding | 54.4M | 53.1M | 50.0M | 40.9M | 40.6M | 39.8M | 3.2M | |
| Weighted Average Number Of Shares Outstanding Basic | 53.7M | 52.2M | 43.0M | 40.7M | 40.3M | 18.5M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 53.7M | 52.2M | 43.0M | 40.7M | 40.3M | 18.5M | ||
| Earnings Per Share Diluted | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | |||
| Earnings Per Share Basic | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 40.3M | 18.5M | 3.1M | 2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.52B | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 53.6M | 53.5M | 53.4M | 52.7M | 52.5M | 50.3M | 41.2M | 41.0M | 40.9M | 40.7M | 40.7M | 40.5M | 40.3M | 40.2M | 37.1M | 3.2M | ||||
| Common Stock Shares Outstanding | 53.6M | 53.5M | 53.4M | 52.7M | 52.5M | 50.3M | 41.2M | 41.0M | 40.9M | 40.7M | 40.7M | 40.5M | 40.3M | 40.2M | 37.1M | 3.2M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 53.6M | 53.4M | 53.4M | 52.7M | 51.8M | 50.1M | 41.1M | 40.9M | 40.9M | 40.7M | 40.7M | 40.6M | 40.2M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 53.6M | 53.4M | 53.4M | 52.7M | 51.8M | 50.1M | 41.1M | 40.9M | 40.9M | 40.7M | 40.7M | 40.6M | 40.2M | |||||||
| Earnings Per Share Diluted | $-0.41 | $-0.49 | $-0.58 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | $-0.40 | |||||||
| Earnings Per Share Basic | $-0.41 | $-0.49 | $-0.58 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | $-0.40 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 40.6M | 40.4M | 40.2M | 40.1M | 29.7M | 3.2M | 3.1M | 3.1M | 3.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.6M | $27.1M | $26.3M | $23.8M | $13.9M | $5.4M | $297.0K | $269.0K |
| Investment Income Interest | $4.0M | $9.4M | $10.6M | $4.3M | $91.0K | |||
| Amortization Of Financing Costs And Discounts | $280.0K | $265.0K | $250.0K | $44.0K | $421.0K | $11.0K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $24.0K | $351.0K | $523.0K | $336.0K | $202.0K | |||
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $27.0K | $75.0K | $92.0K | |||||
| Interest Paid Net | $1.3M | $1.4M | $1.2M | $103.0K | $11.0K | $427.0K | ||
| Costs And Expenses Related Party | $1.1M | $4.4M | $1.9M | |||||
| Vesting Of Early Exercised Stock Options | $27.0K | $75.0K | $92.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.5M | $2.1M | $5.2M | $7.0M | $7.3M | $7.0M | $7.0M | $6.2M | $6.4M | $6.2M | $5.8M | $5.5M | $4.2M | $2.2M | $1.8M | $689.0K | $2.9M | $151.0K | $86.0K | $60.0K | $76.0K |
| Investment Income Interest | $802.0K | $1.1M | $1.5M | $2.3M | $2.6M | $2.6M | $2.7M | $2.7M | $2.3M | $1.4M | $876.0K | $225.0K | |||||||||
| Amortization Of Financing Costs And Discounts | $67.0K | $64.0K | $61.0K | $108.0K | |||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $15.0K | $306.0K | $338.0K | $302.0K | $103.0K | ||||||||||||||||
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $4.0K | $6.0K | $16.0K | $18.0K | $20.0K | $21.0K | |||||||||||||||
| Interest Paid Net | $81.0K | ||||||||||||||||||||
| Costs And Expenses Related Party | $479.0K | $596.0K | $1.1M | $1.2M | |||||||||||||||||
| Vesting Of Early Exercised Stock Options | $16.0K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.